Skip to content
Tariffs and dutiesCBPUnited StatesImportsExports

Guidance: Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients for Products of the United Kingdom Implemented by Presidential Proclamation 11020

1 August 2026

In plain English

CBP guidance under CSMS 69415934 explains reduced tariffs on patented pharmaceuticals and pharmaceutical ingredients that are products of the United Kingdom, per Presidential Proclamation 11020.

Read the official notice
Topic
Tariffs and duties
Regulator
CBP
Published
1 August 2026
For
Imports and Exports
Where it applies
United States
Source
CBP CSMS

From the notice

This message provides guidance regarding the reduction of tariffs on patented pharmaceuticals and associated pharmaceutical ingredients that are products of the United Kingdom amending Presidential Proclamation 11020, “Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States.” BACKGROUND On July 31, 2026, the Secretary of Commerce published “ Notice of Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients for Products of the United Kingdom Implemented by Presidential Proclamation 11020 ” reducing the tariff rate
The full text is at the source

Olive tells you which of these hit your products.

Olive reads every change like these against your own products, codes and trade lanes, whether you import, export or both, and drafts the update to your compliance program for your approval. Nothing changes without you.

Get startedLive demo

Olivra lists official notices for information only. It is not legal advice, and Olive is not a lawyer or a licensed customs broker. The official text at the source is what counts.

More from CBP

See everything Olive monitors